ANI Pharmaceuticals incurred a GAAP loss of $19.347 mln in 6M2010, compared to a profit of $7.034 mln in the previous year. Revenues decreased by 8.4% to $98.244 mln compared to $107.244 mln a year earlier.
ANI Pharmaceuticals incurred a GAAP loss of $19.347 mln in 6M2010, compared to a profit of $7.034 mln in the previous year. Revenues decreased by 8.4% to $98.244 mln compared to $107.244 mln a year earlier. 
investor.anipharmaceuticals.com
English (US) 